Cancer Research

Nventa Presents Findings On Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, At World Vaccine Congress

SAN DIEGO, October 8 /PRNewswire/--- Findings Confirm Potency of Poly-ICR as Vaccine Adjuvant Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly ...

Article - Anna Ohlden - Oct 8 2008 - 6:34am

2008 Nobel Prize In Chemistry Goes To Osamu Shimomura, Martin Chalfie And Roger Y. Tsien For 'Glowing Proteins'

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry for 2008 jointly to Japanese citizen Osamu Shimomura, of Marine Biological Laboratory (MBL), Woods Hole, MA, and Boston University Medical School along with Americans M ...

Article - News Staff - Oct 8 2008 - 1:30pm

Harald Zur Hausen, Françoise Barré-Sinoussi And Luc Montagnier Win 2008 Nobel Prize In Medicine For HPV And HIV Discoveries

The Nobel Assembly at Karolinska Institutet has today decided to award The Nobel Prize in Physiology or Medicine for 2008 with one half to Harald zur Hausen for his discovery of "human papilloma viruses causing cervical cancer" and the other half ...

Article - News Staff - Oct 8 2008 - 1:38pm

Nventa Provides Corporate Update And Advancement Plans For HspE7, Hsp 6/11 And Poly-ICR

SAN DIEGO, October 8 /PRNewswire/--- Company Announces Corporate Restructuring to Focus on Strategic Alliances and M&A Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections ...

Article - Anna Ohlden - Oct 8 2008 - 6:34pm

Senecavirus Structure Revealed (Oh, And It Still Kills Cancer Cells 10,000 Times Better Than Traditional Chemotherapeutics)

The Senecavirus is a "new" virus, discovered several years ago by Neotropix Inc., a biotech company in Malvern, Pennsylvania. It was at first thought to be a laboratory contaminant, but researchers found it was a pathogen, now believed to origin ...

Article - News Staff - Oct 9 2008 - 9:56am

BioWa Licenses POTELLIGENT(R) Technology To CSL Limited

PRINCETON, New Jersey, October 9 /PRNewswire/-- BioWa, Inc. announced today that it has entered into a license agreement with CSL Limited, providing CSL with access to BioWa's POTELLIGENT(R) Technology platform for the research and development of ant ...

Article - Anna Ohlden - Oct 9 2008 - 5:30am

Why The Viral Link To Cancer Deserved The Nobel Prize In Medicine

In today’s world, advances in science and medicine happen almost daily. Few of those discoveries prove to be a revolution in current scientific thought. This is one of those breakthroughs. Recently, the Nobel Committee announced that it would award the Nob ...

Article - Erin Richards - Oct 13 2008 - 10:21am

Merck Serono Named As A Top Employer By Science Magazine

GENEVA, Switzerland, October 10 /PRNewswire/--- Ranked Number 7 out of top 20 Employers Across Life Sciences Industry GENEVA, Switzerland, October 10 /PRNewswire/-- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has be ...

Article - Anna Ohlden - Oct 10 2008 - 12:34am

A New Improved Gene Therapy Can Be The First Treatment For Machado-Joseph Disease

A new improved gene therapy can be the first treatment for Machado-Joseph disease as  Portuguese, Swiss and French researchers show, for the first time, that is possible to inhibit in a living organism the mutated copies of a gene, without affecting any e ...

Article - Catarina Amorim - Sep 1 2014 - 9:11am

Physicians' Group Opposes Fluoridation

“Fluoridation of drinking water is scientifically untenable, and should not be part of a public health initiative or program,” says the Canadian Association of Physicians for the Environment (CAPE) in a new published statement. CAPE is Canada’s leading voi ...

Article - Carol Kopf - Oct 10 2008 - 12:15pm